Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-23-126914
Filing Date
2023-04-28
Accepted
2023-04-28 16:08:00
Documents
2
Group Members
A.T. HOLDINGS II SARLADC PRODUCTS SWITZERLAND SARLAUVEN THERAPEUTICS GENERAL L.P.AUVEN THERAPEUTICS GP LTD.C.T. PHINCO SARLPETER B. CORRSTEPHEN EVANS-FREKE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d466545dsc13da.htm SC 13D/A 143850
2 EX-99.1 d466545dex991.htm EX-99.1 57599
  Complete submission text file 0001193125-23-126914.txt   203219
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Subject) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91517 | Film No.: 23866052
SIC: 2834 Pharmaceutical Preparations

Mailing Address 171 MAIN STREET, ROAD TOWN TORTOLA D8 VG1110
Business Address 171 MAIN STREET, ROAD TOWN TORTOLA D8 VG1110 340-779-6908
AUVEN THERAPEUTICS HOLDINGS LP (Filed by) CIK: 0001812677 (see all company filings)

EIN.: 980619434 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D/A